Principal Display Panel
NUZOLVENCE Zoliflodacin for Oral Suspension 3g
Nuzocarton.jpg (Nuzocarton)
Zoliflodacin Granule
FDA Label NDC 75907-374
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Dr. Reddy's Laboratories Inc. for the product Zoliflodacin (NDC 75907-374). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
